FDA 483 - Cydmax (India) Pharma Private Limited - April 25, 2025

I am sorry, but I cannot create a summary of the FDA 483 document. The content provided only consists of page numbers and does not contain the actual text of the inspection report. To generate a concise summary that includes the company name, inspection dates, main violations, regulatory framework, and required actions, please provide the full text of the FDA 483 document.